Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control

Journal of the American College of Cardiology

Volumn 68, Issue 16, 2016, Pages 1713-1722

  McEvoy, John W ^a,b   Chen, Yuan ^a   Rawlings, Andreea ^a   Hoogeveen, Ron C ^c   Ballantyne, Christie M ^c   Blumenthal, Roger S ^b   Coresh, Josef ^a   Selvin, Elizabeth ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

coronary heart disease; coronary perfusion; high sensitivity troponin; hypertension; J curve

Indexed keywords

ANTIHYPERTENSIVE AGENT; TROPONIN T;

ADULT; AGE DISTRIBUTION; ARTICLE; BLACK PERSON; BODY MASS; CARDIOVASCULAR MORTALITY; CAUCASIAN; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HEART MUSCLE INJURY; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CARDIOMYOPATHIES; COMPLICATION; CORONARY ARTERY DISEASE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STROKE;

BLOOD PRESSURE; CARDIOMYOPATHIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; TROPONIN T;

EID: 84994145085     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.07.754     Document Type: Article

References (32)

1. 1 Hay, J., A British Medical Association lecture on the significance of a raised blood pressure. BMJ 2 (1931), 43–47.
2. 2 Kannel, W.B., Gordon, T., Schwartz, M.J., Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 27 (1971), 335–346.
3. 3 Rosenman, R.H., Sholtz, R.I., Brand, R.J., A study of comparative blood pressure measures in predicting risk of coronary heart disease. Circulation 54 (1976), 51–58.
4. 4 James, P.A., Oparil, S., Carter, B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311 (2014), 507–520.
5. 5 Wright, J.T. Jr., Fine, L.J., Lackland, D.T., et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med 160 (2014), 499–503.
6. 6 Kovell, L.C., Ahmed, H.M., Misra, S., et al. US hypertension management guidelines: a review of the recent past and recommendations for the future. J Am Heart Assoc, 4, 2015, e002315.
7. 7 Lonn, E.M., Bosch, J., Lopez-Jaramillo, P., et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med 374 (2016), 2009–2020.
8. 8 Group, S.R., Wright, J.T. Jr., Williamson, J.D., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
9. 9 Williamson, J.D., Supiano, M.A., Applegate, W.B., et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 315 (2016), 2673–2682.
10. 10 Cruickshank, J.M., Thorp, J.M., Zacharias, F.J., Benefits and potential harm of lowering high blood pressure. Lancet 1 (1987), 581–584.
11. 11 Farnett, L., Mulrow, C.D., Linn, W.D., et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?. JAMA 265 (1991), 489–495.
12. 12 Messerli, F.H., Mancia, G., Conti, C.R., et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann Intern Med 144 (2006), 884–893.
13. 13 Messerli, F.H., Panjrath, G.S., The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?. J Am Coll Cardiol 54 (2009), 1827–1834.
14. 14 Saunders, J.T., Nambi, V., de Lemos, J.A., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123 (2011), 1367–1376.
15. 15 de Lemos, J.A., Drazner, M.H., Omland, T., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304 (2010), 2503–2512.
16. 16 deFilippi, C.R., de Lemos, J.A., Christenson, R.H., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 304 (2010), 2494–2502.
17. 17 Eggers, K.M., Al-Shakarchi, J., Berglund, L., et al. High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am Heart J 166 (2013), 541–548.
18. 18 The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 129 (1989), 687–702.
19. 19 Giannitsis, E., Kurz, K., Hallermayer, K., et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56 (2010), 254–261.
20. 20 White, A.D., Folsom, A.R., Chambless, L.E., et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study: methods and initial two years' experience. J Clin Epidemiol 49 (1996), 223–233.
21. 21 Rosamond, W.D., Folsom, A.R., Chambless, L.E., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 30 (1999), 736–743.
22. 22 The National Survey of Stroke. National Institute of Neurological and Communicative Disorders and Stroke. Stroke 12 (1981), I1–I91.
23. 23 Herndon, J.E. 2nd, Harrell, F.E. Jr., The restricted cubic spline as baseline hazard in the proportional hazards model with step function time-dependent covariables. Stat Med 14 (1995), 2119–2129.
24. 24 Cole, S.R., Hernan, M.A., Constructing inverse probability weights for marginal structural models. Am J Epidemiol 168 (2008), 656–664.
25. 25 Perkovic, V., Rodgers, A., Redefining blood-pressure targets—SPRINT starts the marathon. N Engl J Med 373 (2015), 2175–2178.
26. 26 Pepine, C.J., Handberg, E.M., Cooper-DeHoff, R.M., et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 290 (2003), 2805–2816.
27. 27 Harrison, D.G., Florentine, M.S., Brooks, L.A., Cooper, S.M., Marcus, M.L., The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 77 (1988), 1108–1115.
28. 28 Lindblad, U., Rastam, L., Ryden, L., et al. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ 308 (1994), 681–686.
29. 29 Selvaraj, S., Steg, P.G., Elbez, Y., et al. Pulse pressure and risk for cardiovascular events in patients with atherothrombosis: from the REACH registry. J Am Coll Cardiol 67 (2016), 392–403.
30. 30 Katz, L.N., Feinberg, H., The relation of cardiac effort to myocardial oxygen consumption and coronary flow. Circ Res 6 (1958), 656–669.
31. 31 Stang, A., Moebus, S., Mohlenkamp, S., et al. Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. Am J Epidemiol 164 (2006), 85–94.
32. 32 Eriksson, M., Carlberg, B., Jansson, J.H., Comparison of blood pressure measurements between an automated oscillometric device and a Hawksley random-zero sphygmomanometer in the northern Sweden MONICA study. Blood Press Monit 17 (2012), 164–170.